Aim: To clarify the influence of hypertension on lower urinary tract symptoms (LUTS) we examined the relationship between blood pressure, LUTS, and the effect of terazosin on LUTS in patients with benign prostatic hyperplasia (BPH).
Methods: The subjects were patients who had LUTS and BPH. They were treated with terazosin (1 mg, twice-a-day) for 12 weeks. Calculation of the International Prostate Symptom Score (IPSS), measurement of blood pressure, and uroflowmetry were performed before and after 12 weeks of therapy. Patients were divided into a normotensive (NT) group and a hypertensive (HT) group at the time of first examination.
Results: The IPSS for urinary frequency and nocturia in BPH-HT patients (n = 21; mean age, 71 years) were significantly higher than those in the BPH-NT patients (n = 21; mean age, 69 years) before the administration of terazosin. The total IPSS the BPH-HT patients was also significantly higher than that of the BPH-NT patients. There were no differences of uroflowmetric parameters between the two groups. After 12 weeks of therapy, systolic and diastolic blood pressure decreased in the BPH-HT patients, but not in the BPH-NT patients. However, the systolic pressure of the BPH-HT patients was still significantly higher than that of the BPH-NT patients. The score for each IPSS parameter decreased in both groups, but the difference of the score between the two groups increased.
Conclusion: Hypertension may worsen LUTS and may decrease the improvement of symptoms by terazosin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1442-2042.2003.00707.x | DOI Listing |
Zhonghua Wai Ke Za Zhi
January 2005
Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing 100034, China.
Objective: To assess whether primary hypertension affects the occurrence and progression of benign prostatic hyperplasia (BPH).
Methods: A total of 423 cases of BPH, undergoing transurethral resection of prostate (TURP) or open surgery due to severe low urinary tract symptoms, were reviewed and analyzed. All cases were verified to be BPH postoperatively following histopathological examination.
Int J Urol
November 2003
Department of Urology, Faculty of Medicine, University of the Ryukyus, Uehara, Nishihara, Okinawa, Japan.
Aim: To clarify the influence of hypertension on lower urinary tract symptoms (LUTS) we examined the relationship between blood pressure, LUTS, and the effect of terazosin on LUTS in patients with benign prostatic hyperplasia (BPH).
Methods: The subjects were patients who had LUTS and BPH. They were treated with terazosin (1 mg, twice-a-day) for 12 weeks.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!